Effect of 1334H (Escalating Doses)and Moxifloxacin (400 mg) compared with placebo on QT interval using time-matched 12-lead ECG in healthy subjects: A randomized, double blind, double dummy, single dose preliminary study.

Trial Profile

Effect of 1334H (Escalating Doses)and Moxifloxacin (400 mg) compared with placebo on QT interval using time-matched 12-lead ECG in healthy subjects: A randomized, double blind, double dummy, single dose preliminary study.

Discontinued
Phase of Trial: Phase I/II

Latest Information Update: 15 Nov 2016

At a glance

  • Drugs SUN 1334H (Primary) ; Moxifloxacin
  • Indications Bacterial infections; Perennial allergic rhinitis; Seasonal allergic rhinitis
  • Focus Adverse reactions
  • Sponsors Sun Pharmaceutical Industries
  • Most Recent Events

    • 07 Nov 2016 Status changed from recruiting to discontinued.
    • 23 Apr 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top